Skip to main content
. 2019 Nov 27;222(7):1108–1116. doi: 10.1093/infdis/jiz631

Figure 4.

Figure 4.

Human immunodeficiency virus reverse-transcriptase inhibitor resistance-associated mutations enriched in virologically failing participants (n = 1445) with M184V/I. Mutations are shown that occurred in at least 10% of individuals with M184V/ at a significance level of <.001.